MedPath

Randomized-controlled Trial (RCT) on CPAP-withdrawal and Microvascular Function in OSA

Not Applicable
Completed
Conditions
Obstructive Sleep Apnoea
Interventions
Other: CPAP therapy withdrawal
Procedure: Continue CPAP treatment
Registration Number
NCT01797653
Lead Sponsor
University of Zurich
Brief Summary

Randomized controlled trial (therapeutic vs. placebo CPAP) including 46 patients with obstructive sleep apnea (OSA) to define the physiological effects of continuous positive airway pressure (CPAP) therapy withdrawal on myocardial perfusion and dermal and renal microvascular function during a 2 week period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo CPAPCPAP therapy withdrawalpatients established on CPAP therapy, who are randomized to the placebo comparator, will use a CPAP device with subtherapeutic pressure during two weeks.
therapeutic CPAPContinue CPAP treatmentpatients who are randomized to the active comparator, will continue with CPAP treatment with therapeutic pressure during two weeks
Primary Outcome Measures
NameTimeMethod
hyperaemic myocardial blood flow2 weeks
Secondary Outcome Measures
NameTimeMethod
Coronary flow reserve2 weeks

Coronary flow reserve determined by PET

Urine albumine excretion rate2 weeks
Dermal microvascular vasodilatory response2 weeks

Trial Locations

Locations (1)

University Hospital Zurich, Division of Pneumology

🇨🇭

Zurich, ZH, Switzerland

© Copyright 2025. All Rights Reserved by MedPath